Davis AE, Brogan AJ, Goodwin B, Nocea G, Lozano V. Short-term cost and efficiency analysis of raltegravir versus atazanavir/ritonavir or darunavir/ritonavir for treatment-naive adults with HIV-1 infection in Spain. HIV Clin Trials. 2017 Nov;18(5-6):214-22. doi: 10.1080/15284336.2017.1402144
Croft DE, van Hemert J, Wykoff CC, Clifton D, Verhoek M, Fleming A, Brown DM. Precise montaging and metric quantification of retinal surface area from ultra-widefield fundus photography and fluorescein angiography. Osli Retina. 2014 Jul 1;45(4):312-7. doi: 10.3928/23258160-20140709-07
Muth MK, Zhen C, Taylor J, Cates S, Kosa K, Zorn D, Choiniere C. The value to consumers of health labeling statements on breakfast foods and cereals. Journal of food products marketing. 2013 Jul;19(4):279-98. doi: 10.1080/10454446.2013.724372
Brogan AJ, Mrus J, Hill A, Sawyer AW, Smets E. Comparative cost-efficacy analysis of darunavir/ritonavir and other ritonavir-boosted protease inhibitors for first-line treatment of HIV-1 infection in the United States. HIV Clin Trials. 2010 May;11(3):133-44.
Watts (Wideman) K, McAvinchey G, Quiroz R. Language services in survey research. ATA Chronicle. 2002 Jul;31(7):36-7.